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Background: We could previously identify components of both the innate and the adaptive immune system as
disease modifiers in the pathogenesis of models for Charcot-Marie-Tooth (CMT) neuropathies type 1B and 1X.
As part of the adaptive immune system, here we investigated the role of antibodies in a model for CMT1B.
Methods: Antibodies were localized and characterized in peripheral nerves of the CMT1B model by
immunohistochemistry and Western blot analysis. Experimental ablation of antibodies was performed by cross
breeding the CMT1B models with mutants deficient in B-lymphocytes (JHD−/− mutants). Ameliorated demyelination
by antibody deficiency was reverted by intravenous injection of mouse IgG fractions. Histopathological analysis
was performed by immunocytochemistry and light and quantitative electron microscopy.
Results: We demonstrate that in peripheral nerves of a mouse model for CMT1B, endogenous antibodies strongly
decorate endoneurial tubes of peripheral nerves. These antibodies comprise IgG and IgM subtypes and are
preferentially, but not exclusively, associated with nerve fiber aspects nearby the nodes of Ranvier. In the absence
of antibodies, the early demyelinating phenotype is substantially ameliorated. Reverting the neuropathy by
reconstitution with murine IgG fractions identified accumulating antibodies as potentially pathogenic at this early
stage of disease.
Conclusions: Our study demonstrates that in a mouse model for CMT1B, endogenous antibodies contribute to
early macrophage-mediated demyelination and disease progression. Thus, both the innate and adaptive immune
system are mutually interconnected in a genetic model for demyelination. Since in Wallerian degeneration antibodies
have also been shown to be involved in myelin phagocytosis, our study supports our view that inherited demyelination
and Wallerian degeneration share common mechanisms, which are detrimental when activated under nonlesion
conditions.
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Charcot-Marie-Tooth (CMT) type 1 disorders comprise a
genetically heterogeneous group of inherited peripheral
neuropathies that are characterized by length-dependent
axonal degeneration, muscle atrophy, and sensory dysfunc-
tion, substantially reducing quality of life [1,2]. Although in
the last years several culprit genes could be identified, pres-
ently no causative treatment is available [3,4].* Correspondence: rudolf.martini@mail.uni-wuerzburg.de
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unless otherwise stated.Our group could identify low-grade inflammation as a
substantial disease modifier in the pathogenesis of distinct
CMT1 mouse models [5]. While in models for CMT1A,
macrophages were identified as the only inflammation-
related disease modulators [6,7], disease outcome in
models for CMT1B and CMT1X is influenced by com-
ponents of both the innate [8-12] and the adaptive im-
mune system [13-15].
Based on the finding that antibodies, a humoral compo-
nent of the adaptive immune system, are involved in mye-
lin phagocytosis after peripheral nerve lesion [16] and duehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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degeneration and pathogenesis of CMT [5], we investi-
gated the role of antibodies in a demyelinating model
for CMT1B.
We demonstrate here that endoneurial tubes of periph-
eral nerves of P0het myelin mutant mice are decorated
with endogenous antibodies. Furthermore, by crossbreed-
ing P0het mice with mouse mutants specifically lacking
B-lymphocytes and antibodies (JHD−/−), we show a sig-
nificant amelioration of demyelination and a reduction of
macrophages in peripheral nerves of young P0het JHD−/−
mice. Passive systemic transfer of antibodies (IgGs) into
P0het JHD−/− mice restored antibody decoration and
reverted reduced macrophage elevation and impaired
nerve histology, suggesting a role of endogenous anti-
bodies in macrophage-mediated demyelination. Our study
therefore identifies endogenous antibodies as a link in the
interaction between the innate and adaptive immune sys-
tem during early pathogenesis in a model for CMT1B.
Methods
Animals
Mice heterozygously deficient for P0 (P0het; [17]) were
crossbred to animals specifically lacking B-lymphocytes
(JHD−/−; [18]) according to previously published proto-
cols [13] and investigated at the age of 1 and 6 months
with the corresponding littermates of both gender. As
additional controls, RAG1-deficient mice, lacking both
B- and T-lymphocytes, were analyzed [19]. All mice were
on a C57BL/6 N background, and genotypes were identi-
fied after purification of genomic DNA from ear biopsies
using DNeasy Blood & Tissue Kit (Qiagen, Venlo, The
Netherlands) according to the manufacturer’s guidelines.
Genotypes of P0 mutants were determined by conven-
tional PCR using oligonucleotides 5′-TCAGTTCCTT
GTCCCCCGCTCTC-3′, 5′-GGCTGCAGGGTCGCTC
GGTGTTC-3′, and 5′-ACTTGTCTCTTCTGGGTAAT
CAA-3′ leading to 334 or 500 bp products for the P0
null mutation or wildtype allele; genotypes of JHD mu-
tants with oligonucleotides 5′-GAGGAGACGGTGAC
CGTGGTCCCTGC-3′, 5′-GGACCAGGGGGCTCAGG
TCACTC-AGG-3′, 5′-GCCGCATTGCATCAGCCATG
AT-GGA-3′, and 5′-CCTTGCGCAGCTGTGC-TCGA
CGTTG-3′ leading to 180 or 195 bp products for the
JHD null mutation or wildtype allele; genotypes of RAG1
mutants with oligunucleotides 5′-GAGGTTCCGCTAC
GACTCTG-3′, 5′-CCGGACAAGTTTTTCAT-CGT-3′,
and 5′-TGGATGTGGAATTGTTGCGAG-3′ leading
to 530 or 474 bp products for the RAG1 null mutation
or wildtype allele, respectively. Animals were kept in
the animal facility of the Department of Neurology,
University clinic of Würzburg, in a 12 h/12 h day (<300
lux)/night rhythm under barrier conditions using indi-
vidually ventilated cages. All animal experiments wereapproved by the local authority, the Government of
Lower Franconia, Germany.
Sciatic nerve crush injury
Wildtype mice were deeply anesthetized by an intraperi-
toneal injection of a mixture of ketamine and xylazine
(10 μl per g body weight). The right sciatic nerve was ex-
posed and crushed at the region of the sciatic notch by
using a non-serrated clamp using a constant pressure for
15 s. This resulted in a completely translucent appear-
ance of the crushed area of the nerve. After 3 days, the
mice were sacrificed and lesioned nerves were removed
for analysis of complement deposition (see below).
Tissue processing
For preparation of fresh frozen spleens and femoral
nerves, animals were killed by asphyxiation with CO2
(according to guidelines by the State Office of Health
and Social Affairs Berlin), blood was transcardially rinsed
with phosphate-buffered saline (PBS) containing heparin,
followed by harvesting and embedding nerves in O.C.T.
medium (Sakura, Alphen aan den Rijn, The Netherlands)
and frozen in liquid nitrogen-cooled methyl butane.
For preparation of fixed femoral nerves, blood of
sacrificed mice (see above) was transcardially rinsed
with PBS/heparin followed by perfusion with 4% para-
formaldehyde (PFA) in PBS for 10 min. Dissected nerves
were post-fixed in the same solution for 2 h, rinsed in 30%
sucrose/PBS overnight at 4°C, and embedded in O.C.T.
medium. Peripheral nerves were cut into 10 μm-thick
cross sections on a cryostat (Leica, Solms, Germany) and
stored at −20°C.
Single teased-fiber preparations were processed as de-
scribed elsewhere [20]. Briefly, blood was transcardially
rinsed with PBS/heparin followed by perfusion with 2%
PFA in PBS for 10 min. Femoral quadriceps nerves were
dissected, and single fibers were separated by forceps on
glass slides.
For electron microscopy, femoral quadriceps nerves were
processed as described previously [11]. In short, mice were
transcardially perfused with 4% PFA and 2% glutaraldehyde
in 0.1 M cacodylate buffer. Dissected nerves were post-
fixed in the same solution overnight at 4°C. After osmifica-
tion and dehydration, samples were embedded in Spurr’s
medium. Ultrathin sections (80 nm) were mounted to cop-
per grids and counterstained with lead citrate.
Immunohistochemistry
For identification of endogenous antibodies on nerve
cross sections or teased fibers, PFA-fixed samples were
blocked with 10% bovine serum albumin (BSA) and 1%
normal goat serum (NGS) in 0.1 M PBS, followed by
incubation with Cy3-conjugated goat-anti-mouse IgG-
Fc antibodies (1:300, 715-166-150, Dianova, Hamburg,
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at room temperature. Alternatively, samples were incu-
bated overnight with non-coupled rabbit-anti-mouse
IgG-Fc (1:1,000, 31194, Thermo Scientific, Waltham,
MA, USA) at 4°C, followed by incubation with the corre-
sponding Cy3-conjugated secondary antibodies for 1 h
(1:300, 111-165-144, Dianova). To determine whether
endogenous nerve antibodies are bound to extra- or intra-
cellular domains, unfixed and non-permeabilized native
sciatic nerves were loosely teased and incubated free float-
ing in a 96-well plate. IgG-Fc staining was performed simi-
larly as described above. To control for internal antibody
deposition, nerve fibers were permeabilized by repeated
cycles of freezing in liquid nitrogen and thawing. Incuba-
tion with rabbit-anti-mouse β-III-Tubulin (1:500, ab18207,
Abcam, Cambridge, UK) and detection with the corre-
sponding Cy3-conjugated secondary antibodies for 1 h
(1:300, 111-165-144, Dianova) were additionally per-
formed and served as positive controls for successful
permeabilization and internal antibody binding.
Complement deposition was identified on teased fiber
preparations. Briefly, samples were fixed in acetone
(10 min, −20°C), blocked with 5% NGS with 0.3%
TritonX-100 in 0.1 M PBS, and incubated with FITC-
conjugated goat-mouse C3 (1:100, 0855500, MP Bio-
medicals, Santa Ana, CA, USA) in 1% NGS with 0.3%
TritonX-100 in 0.1 M PBS for 1 h at room temperature.
As positive controls, teased fibers from distal parts of
lesioned sciatic nerves (3 days after crush) were identically
treated as uninjured nerves of mutant mice. Diaphragms,
incubated ex vivo with anti-ganglioside monoclonal anti-
bodies and normal human serum [21], were investigated
for complement deposition as lesioned nerves, whereby
postsynaptic terminals were identified with Alexa Fluor
555-conjugated α-Bungarotoxin (1:300, B35451, Molecular
Probes, Life Technologies, Carlsbad, CA, USA).
Quantification of endoneurial macrophages was per-
formed on cross sections according to previously pub-
lished protocols [8,11]. Briefly, fresh-frozen samples were
fixed in acetone (10 min, −20°C) and blocked with 5%
BSA in 0.1 M PBS, followed by an avidin-biotin blocking
step (SP-2001, Vector Laboratories, Burlingame, CA,
USA); biotinylated rat-anti-F4/80 (1:300, MCA497B,
Serotec, Kidlington, UK) primary antibodies in 1% BSA
in 0.1 M PBS were applied for 1 h at room temperature
and detected by Cy3-conjugated Streptavidin (1:100,
CED-CLCSA1010, Biozol, Eching, Germany). Nuclei were
labeled with DAPI (Sigma-Aldrich, St. Louis, MO, USA).
Whole nerve cross sections were analyzed, and the mean
number of macrophages per section in seven to ten con-
secutive sections per animal was calculated.
Determination of B-lymphocytes was performed on
cross sections of the spleen. In short, fresh-frozen sam-
ples were fixed in acetone (10 min, −20°C), blocked with5% BSA in 0.1 M PBS and incubated with rat-anti-B220/
CD45R (1:100, 550286, BD Pharmingen, San Jose, CA,
USA) primary antibodies in 1% BSA in 0.1 M PBS
overnight at 4°C, and detected by Cy3-conjugated sec-
ondary antibodies (1:300, 112-165-167, Dianova).
Digital fluorescence microscopic images were acquired
using an Axiophot 2 microscope (Zeiss, Oberkochen,
Germany) equipped with a CCD camera (Visitron Systems,
Puchheim, Germany) and afterwards processed with
Photoshop CS3 (Adobe, San Jose, CA, USA). IgG fluor-
escence intensity in the endoneurium of femoral quadri-
ceps nerve cross sections was measured with ImageJ
(NIH, Bethesda, Maryland). Briefly, images were converted
to 32-bit grayscale images and the mean gray value was
calculated to determine immunoreactive signals, taking
the mean gray value of P0wt nerves as a reference value.
Data is shown as the mean of n = 2 per genotype of three
repeated stainings and measurements. At least three sec-
tions per animal and experiment were analyzed.
Western blot analysis
Determination of protein concentrations and Western
blot analysis were performed as previously described [11].
Briefly, animals were killed by asphyxiation with CO2,
blood was rinsed with PBS/heparin, and femoral quadri-
ceps nerves were quickly dissected and snap frozen in
liquid nitrogen. After sonification (Sonoplus HD60,
Bandelin Electronic, Berlin, Germany) in 100 μL RIPA
lysis buffer per 10 mg tissue, protein concentration was
determined by a Lowry assay (Sigma-Aldrich). Proteins
were resolved by sodium dodecyl sulfate-polyacrylamide.
After gel electrophoresis (SDS-PAGE with 10% Acryl-
amide), proteins were transferred to a nitrocellulose
membrane and visualized with Ponceau S (Roth, Newport
Beach, CA, USA). Membranes were blocked with 5%
skimmed milk in PBST and incubated with rabbit-anti-
ERK1/2 (1:10,000, sc-94, Santa Cruz Biotechnology,
Dallas, TX, USA) antibody solution overnight at 4°C.
Corresponding horseradish peroxidase (HRP)-conjugated
secondary antibodies (1:3,000, NA9340V, GE Health-
care, Little Chalfont, UK) were probed for 1 h at room
temperature, and detection of the immune reaction was
determined by ECL reagent and ECL hyperfilm (GE
Healthcare Bio-Sciences AB). Endogenous antibodies
were detected by directly labeled HRP-anti mouse IgG-Fc
antibodies (1:5,000, 115-035-008, Dianova) overnight at
4°C or for 2 h at room temperature. Densitometric ana-
lyses were performed with Image J (NIH) and depicted as
the ratio of IgG to ERK1/2. Results from two independent
experiments are shown.
Morphological analysis
Multiple image alignments were acquired, and abnormally
myelinated fibers, consisting of thinly and demyelinated
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fied in relation to the total number of axons in cross sec-
tions of the femoral quadriceps nerve. The g-ratio was
determined by dividing the diameter of the axon by the
diameter of the same axon including its myelin sheath. At
least 125 fibers per animal were randomly selected and
analyzed. Analysis was performed using a ProScan Slow
Scan CCD camera mounted to a Leo 906E electron micro-
scope (Zeiss) with corresponding iTEM software (Olym-
pus Soft Imaging Solutions GmbH, Münster, Germany).
Reconstitution experiments
150 μg of mouse IgGs (PMP01, Serotec) or mouse-anti-
keyhole limpet hemocyanin (KLH)-antibody (orb11067,
Biorbyt, Cambridge, UK) or 50 μg mouse IgG Fc frag-
ments (31205, Pierce, Rockford, IL, USA) were injected
into the tail vein (i.v.) once or at four consecutive weeks
followed by analysis 1 week later. After dissection and
tissue processing, specific binding of antibodies in per-
ipheral nerves was controlled by immunohistochemistry
and Western blot analysis.
Statistical analysis
All experiments were performed in a blinded manner,
with the investigators unaware of the genotypes of the
analyzed mice. Data sets were controlled for normal
distribution by Shapiro-Wilk test. Comparison of more
than two groups with normally distributed data (paramet-
ric) was tested by one-way ANOVA, followed by Tukey
post hoc test or Bonferroni-Holm correction. In the case
of non-normally distributed data sets, the nonparametric
Kruskal-Wallis test with Bonferroni-Holm correction was
applied. Significance levels (*, # P < 0.05; **, ## P < 0.01;
***, ### P < 0.001) are indicated together with the applied
statistical tests within the figure legends. Quantifications
are shown as mean + SD. Statistical analyses were per-
formed using PASW Statistics 18 (SPSS, IBM, Armonk,
NY, USA) software, and diagrams were generated with
Microsoft Excel 2007.
Results
Antibodies accumulate in peripheral nerves of P0het
myelin mutant mice
In order to detect antibody binding, we performed im-
munohistochemical stainings for IgGs on femoral nerve
cross sections from 6-month-old P0het mutant mice and
P0wt littermates. We found a strong antibody deposition
in the perineurium of femoral quadriceps nerves of both
P0wt and P0het mutants (Figure 1A). However, in the
endoneurium of mutant nerves, a higher IgG immuno-
reactivity was observed compared to wildtype controls
which could be confirmed by IgG signal intensity mea-
surements (Figure 1A,B). Of note, in the non-affected
sensory branch of the femoral nerve (saphenous nerve),this prominent antibody deposition could not be detected
in P0het mutant mice (Figure 1A). We also performed
IgG immunocytochemistry on single teased-fiber prepara-
tions, in order to detect potentially preferred antibody de-
positions along myelinated nerve fibers. Indeed, we could
confirm a stronger deposition along myelinated fibers in
P0het mice compared to wildtype controls, with strongest
IgG immunoreactivity at nodes of Ranvier (Figure 1D).
To determine whether endogenous nerve antibodies are
bound to extra- or intracellular domains, nerve fibers of
unfixed and non-permeabilized sciatic nerves of P0het
mice were loosely teased and stained free floating for
IgG and β-III-Tubulin. Again, IgG immunoreactivity
could be detected along myelinated nerve fibers indicating
external deposition of endogenous antibodies, whereas
β-III-Tubulin immunoreactivity was confined to some
axonal profiles at nodes of Ranvier (Figure 1E), likely
reflecting the vulnerability of this structure by mechanical
teasing. As controls for the accessibility of intracellular do-
mains by permeabilization, nerve fibers were repeatedly
frozen in liquid nitrogen followed by incubation with
antibodies to IgGs or β-III-Tubulin. As expected, only
after permeabilization, β-III-Tubulin staining showed an
extended immunoreactivity along the entire axon includ-
ing internodes, while IgG immunoreactivity was still vis-
ible along the outer margins of the myelinated fibers
(Figure 1E). Thus, endogenous antibodies bind to extracel-
lular domains of peripheral nerve fibers.
In order to substantiate our immunocytochemical find-
ings, we performed Western blot analysis of peripheral
nerve extracts using antibodies to mouse IgG and IgM
subtypes. We found increased IgG (Figure 1F,G) and
IgM signals (not shown) in P0het mice in comparison to
extracts from P0wt mice, corroborating the immuno-
cytochemical observations. Specificity of the respective
staining was further controlled by performing immuno-
cytochemistry and Western blot analysis in RAG1-
deficient mice, lacking T- and B-lymphocytes (and,
therefore, antibodies). As expected, this resulted in a
complete lack of decorating antibodies in peripheral
nerves (Figure 1). We also investigated antibody depos-
ition in 1-month-old P0het mice and P0wt littermates,
an early time point in disease before features typical for
demyelination are morphologically visible. Indeed, by
immunohistochemistry (Figure 1C) and Western blot ana-
lysis (not shown), we detected already at this early age a
similarly elevated IgG immunoreactivity in the mutant
nerves as at 6 months of age. However, perineurial stain-
ing was substantially weaker.
Our data suggest that specific endogenous antibodies
bind to extracellular domains of endoneurial tubes in per-
ipheral nerves of myelin mutant mice, a potential early
prerequisite for modulating pathogenesis in an animal
model for CMT1B.
Figure 1 (See legend on next page.)
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Figure 1 Antibodies accumulate in peripheral nerves of myelin mutant mice. (A) Immunohistochemical localization of endogenous
antibodies (IgG) in the femoral quadriceps (q) and saphenous nerve (s) from 6-month-old wildtype mice (P0wt) and myelin mutants (P0het).
Note the prominent labeling of the endoneurium in nerve cross sections in femoral quadriceps nerves of mutants in contrast to wildtype mice.
RAG1-deficient mice (deficient for T- and B-lymphocytes) are, expectedly, devoid of antibody deposition. Scale bar, 20 μm. (B) IgG fluorescence
intensity in the endoneurium of femoral quadriceps nerve cross sections is shown as the mean gray value, taking P0wt nerves as a reference. n = 2
animals per genotype were analyzed within three repeated stainings and measurements. (C) Immunohistochemical localization of endogenous
antibodies (IgG) in the femoral quadriceps (q) and saphenous nerve (s) from 1-month-old wildtype mice (P0wt) and myelin mutants (P0het).
Note similar endoneurial immunoreactivity in comparison to 6-month-old mutants (see A), but the lower intensity of the perineurium. Scale
bar, 20 μm. (D) Immunocytochemical staining against IgG on single fiber preparations. Note preferential deposition of antibodies in the nodal
regions and the generally stronger signal along myelinated fibers in P0het mice compared to wildtype mice. Nerve-specific antibodies are not
detectable in RAG1-deficient mice. The corresponding phase contrast micrograph displays the teased fiber with a node of Ranvier (arrowheads).
Scale bar, 20 μm. (E) Immunocytochemical staining against IgG or β-III-Tubulin on unfixed and non-permeabilized native sciatic nerve fibers
of P0het mice (left and middle column). Note IgG immunoreactivity along the outer margins of the myelinated nerve fibers and at nodes of
Ranvier (arrowhead, left column) whereas β-III-Tubulin-immunoreactivity is confined to some axonal profiles at nodes of Ranvier (arrowheads,
middle column), likely due to the vulnerability of this structure upon teasing. In the permeabilized sciatic nerve samples of P0het mice, β-III-Tubulin
immunoreactivity is now visible along the entire axon (arrows, lower right column) and no longer confined to nodes (see middle columns), whereas
IgG immunoreactivity is still detectable along myelinated fibers (upper right column). White dashed lines indicate outer margins of myelinated
nerve fibers. Scale bar, 20 μm. (F) Western blot analysis of wildtype (P0wt) and P0het femoral quadriceps nerve lysates showing stronger IgG
signal in mutant mice. RAG1-deficient mice show no antibody signal. ERK1/2 serves as a loading control. (G) Densitometric analysis of IgG
immunoreactivity in Western blots from P0het mutant mice and P0wt littermates, taking ERK1/2 signal as a reference (loading control). Results
of n = 2 to 3 from two independent experiments are depicted.
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Deposition of antibodies is often associated with the clas-
sical or alternative pathways of complement activation
[22,23]. We, therefore, investigated whether in our P0het
mice, C3, a central component of both pathways, is depos-
ited on mutant nerve fibers. By immunohistochemistryFigure 2 Lack of evidence for complement deposition in peripheral n
C3 on single teased-fiber preparations. Complement deposition is detectab
crush) but not in nonlesioned sciatic nerves from 6-month-old P0wt and P
also shown. (B) Immunohistochemical staining against C3 (green) and α-Bu
deposition is detectable at presynaptic terminals. Blue profiles in merged musing a C3-specific antibody, we failed to identify com-
plement deposition, while - as positive controls - C3
deposition was amply detectable on nerve fibers of
crushed nerves [24] and on explanted diaphragms incu-
bated with anti-ganglioside antibodies and normal hu-
man serum [21] (Figure 2).erve fibers of P0het mice. (A) Immunocytochemical staining against
le in teased fibers from crushed wildtype sciatic nerves (3 days post
0het mice. Corresponding phase contrast (PC) micrographs are
ngarotoxin (αBTX, red) on diaphragm cross section. Complement
icrographs are DAPI-labeled nuclei. Scale bars, 5 μm.
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P0het JHD−/− mice
In order to identify the role of antibodies in a model for
CMT1B, we crossbred P0het mice with JHD-deficient
mutants that lack B-lymphocytes and are, thus, incap-
able to produce antibodies. As expected, JHD−/− mice
were devoid of B-lymphocytes in the spleen and anti-
bodies in peripheral nerves as revealed by immunohisto-
chemistry and Western blot analysis (Figure 3).
Next, we investigated the number of macrophages in
P0wt and P0het mice either positive or homozygously
deficient for JHD (Figure 4). Numbers of macrophages
were significantly elevated in femoral quadriceps nerves of
6-month-old P0het mice when compared to age-matched
wildtype mice, confirming previous observations [8,9].
Interestingly, P0het mice additionally deficient for JHD
and lacking endogenous antibodies showed a signifi-
cantly attenuated elevation of F4/80-positive macrophages
(Figure 4A,B). However, in pathologically non-affected sa-
phenous nerves, the number of macrophages was not
altered in single and double mutant mice (Figure 4A,B).
We additionally focused on macrophage activation by
electron microscopy. We found a substantial number of
macrophages only in P0het mice that were JHD positive,
whereas all other genotypes, including P0het JHD−/−
mice, lacked foamy macrophages (Figure 4C).
Antibody deficiency ameliorates the demyelinating
phenotype in P0het mutant mice
As a next step, we investigated whether absence of anti-
bodies in P0het JHD−/− mice leads to an alleviation of
demyelination, a typical feature of our CMT1B mouseFigure 3 JHD-deficient mice lack B-lymphocytes and antibodies. (A) Im
wildtype controls and JHD-deficient mice. Note lack of immunoreactivity in
detectable in 6-month-old femoral quadriceps (q) and saphenous (s) nerve
microscope image is also shown. Scale bar, 20 μm. (C) Western blot analys
ERK1/2 serves as a loading control.model. Quantification by electron microscopy of profiles
indicative of pathological alterations revealed a significant
reduction of abnormally myelinated fibers and of super-
numerary Schwann cells (‘onion bulbs’) in P0het JHD−/−
mice compared to P0het JHD+/+ mice at 6 months of age
(Figure 5). Moreover, quantification of the g-ratio (axon
diameter/fiber diameter) showed a significant increase in
myelin thickness in P0het JHD−/− compared to P0het
JHD+/+ mice (Figure 5D) demonstrating an improved
myelin integrity. Thus, endogenous antibodies seem to
contribute to early macrophage-mediated demyelination
in P0het myelin mutant mice.
Passive transfer of antibodies reverts the ameliorated
demyelinating phenotype in P0het JHD−/− mice and
suggests antigen specificity
In order to clarify the role of endogenous antibodies in
the pathogenesis in a model for CMT1B, we performed
reconstitution experiments into P0het JHD−/− mice to
determine if antibodies can revert the observed benefi-
cial effects. We performed i.v. injections of IgGs either
once or on four consecutive weeks and analyzed mice at
the age of 6 months. By immunohistochemistry, we found
that after passive transfer into P0het JHD−/− mice, IgGs
accumulated on endoneurial tubes of peripheral nerves
comparable to P0het JHD+/+ mice, although to a weaker
degree (Figure 6A). IgG deposition was increased in
femoral quadriceps nerves after four weekly injections
compared to mice that received only a single IgG injection
(Figure 6A). The passive transfer led not only to in-
creased antibody detection in nerve sections but also to
elevated numbers of F4/80-positive macrophages andmunohistochemical staining against B220-positive B-lymphocytes in
JHD-deficient mice. Scale bar, 50 μm. (B) IgG deposition was not
s from JHD-deficient mice. The corresponding phase contrast (PC)
is confirms the lack of endogenous antibodies in JHD-deficient mice.
Figure 4 Reduced macrophage numbers in P0het mice lacking endogenous antibodies. (A) Immunohistochemistry against macrophages
(F4/80) in cross sections of femoral nerves from 6-month-old wildtype (P0wt JHD+/+), single (P0het JHD+/+), and double mutants (P0het
JHD−/−). Representative micrographs are shown. Dashed circles indicate the femoral quadriceps (q) and saphenous nerve (s). Scale bar, 20 μm.
(B) Quantification of F4/80-positive profiles showing a significant reduction of macrophage numbers in femoral quadriceps nerve from P0het
JHD−/− double mutants in comparison to single mutants. In the saphenous nerve, the number of macrophages is not increased in mutants
(n = 4 to 5). One-way ANOVA with Tukey post hoc test. # (significant difference to P0wt), * (significant difference between P0het mutant groups).
#, *P < 0.05; ##, **P < 0.01; ###, ***P < 0.001. (C) Quantification of foamy macrophages reveals an absence of phagocytosing macrophages in
femoral quadriceps nerves from P0het JHD−/− mice (n = 4 to 5). Kruskal-Wallis test with Bonferroni-Holm correction. # (significant difference to
P0wt), * (significant difference between P0het mutant groups). #, *P < 0.05. n.d. (not detected).
Figure 5 Antibody deficiency ameliorates myelin degeneration in P0het mutants. (A) Representative ultrathin sections of femoral quadriceps
nerves from 6-month-old wildtype (P0wt JHD+/+), single (P0het JHD+/+), and double mutants (P0het JHD−/−). Asterisks indicate abnormally
myelinated fibers and arrows supernumerary Schwann cells (‘onion bulbs’). Scale bar, 5 μm. (B, C) Quantification of abnormally myelinated fibers
(B) and onion bulbs (C) demonstrate signs of significant amelioration of demyelination and improved myelin integrity in P0het JHD−/− double
mutants in comparison to P0het JHD+/+ mice (n = 4 to 5). Kruskal-Wallis test with Bonferroni-Holm correction, # (significant difference to P0wt),
* (significant difference between P0het mutant groups). #, *P < 0.05. n.d. (not detected). (D) Quantification of the g-ratio (axon diameter/fiber
diameter) demonstrates a significant increase in myelin thickness in P0het JHD−/− compared to P0het JHD+/+ mice (n = 4, 125 to 135 axons
per animal). Two-tailed Student’s t-test. *P < 0.05.
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Figure 6 Antibodies accumulate in peripheral nerves after passive transfer and lead to macrophage increase. (A) Immunohistochemical
localization of antibodies after systemic injection of IgG in the femoral quadriceps (q) and saphenous nerve (s) from 6-month-old P0wt JHD−/−
(7 days post injection, DPI) and P0het JHD−/− mice (7DPI and 28DPI). Note stronger IgG immunoreactivity in the endoneurium from P0het
JHD−/− mice that received consecutive IgG injections over 28 days (28DPI). Scale bar, 20 μm. (B) Quantification of F4/80-positive profiles in
non-injected control and reconstituted mice showing an increase of macrophage numbers in femoral quadriceps nerve from P0het JHD−/−
mutants after IgG reconstitution (n = 3 to 5). One-way ANOVA with Bonferroni-Holm correction. *P < 0.05. (C) Quantification of foamy macrophages
reveals an increase of phagocytosing macrophages in femoral quadriceps nerves from P0het JHD−/− mice after IgG reconstitution. Note also the
presence of phagocytosing macrophages in control-reconstituted animals (+KLH, +IgG Fc) (n = 3 to 5). Kruskal-Wallis test with Bonferroni-Holm
correction. *P < 0.05. n.d. (not detected).
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to P0het JHD+/+ mutants (Figure 6B,C), whereas anti-
body reconstitution had no effect on numbers of puta-
tive resident macrophages in P0wt JHD−/− mice (not
shown). To analyze the pathogenic impact of injected
antibodies, we quantified nerve fiber damage by elec-
tron microscopy. P0wt JHD−/− showed no pathological
alterations after IgG injections (Figure 7A). However,
IgG injections reverted the ameliorated phenotype of
P0het JHD−/− mice, as determined by an increased num-
ber of abnormally myelinated fibers and supernumerary
Schwann cells (Figure 7B,C), suggesting that antibodies
are sufficient to aggravate nerve damage along with
macrophage-mediated demyelination.
Finally, we investigated whether antigen specificity is
needed for the detrimental effect of antibodies. We per-
formed passive transfer experiments into P0het JHD−/−
mice using mouse antibodies that show specificity for a
non-mammalian antigen, like keyhole limpet hemocyanin
(KLH), or mouse-IgG Fc fragments. Expectedly, in both
cases, we failed to demonstrate antibody binding to per-
ipheral nerves by immunohistochemistry (not shown).
Unexpectedly, we could observe a slight, non-significant
increase of total macrophage numbers after injection of
non-specific IgGs or mouse-IgG Fc fragments in indi-
vidual animals (Figure 6B) together with an increase
of phagocytosing macrophages (Figure 6C). Consistent
with this macrophage activation, we could also detectslightly increased nerve fiber damage after reconstitu-
tion (Figure 7), suggesting that antibodies not binding
to neural tissue can activate macrophages and contribute
to demyelination in peripheral nerves of P0het mice.
Discussion
In the present work, we demonstrate that in peripheral
nerves of P0het mice, a model for CMT1B, endogenous
antibodies strongly decorate endoneurial tubes of per-
ipheral nerves whereas nerve fibers of wt mice are only
weakly labeled. These antibodies comprise IgG and
IgM subtypes and are preferentially, but not exclu-
sively, associated with nerve fiber aspects nearby nodes
of Ranvier. Furthermore, in the absence of antibodies,
the early demyelinating phenotype is substantially amelio-
rated. Reverting the neuropathy by reconstitution with
murine IgG fractions identified accumulating antibodies
as potentially pathogenic at this early stage of disease.
Antibody deposition as an accelerator of myelin phago-
cytosis has recently been demonstrated for nerve injury,
inducing Wallerian degeneration [16]. After crush injury,
endogenous, preexisting antibodies were strongly accumu-
lated along endoneurial tubes of the lesioned as opposed to
intact nerves, where similarly weak labeling was detected
as in our wt control mice. At least a subpopulation of these
systemic antibodies has been identified to recognize the
myelin component P0/MPZ. Based on the similar stain-
ing patterns obtained and the systemic presence of such
Figure 7 Antibody reconstitution reverts the ameliorated demyelinating phenotype in P0het JHD−/− mice. (A) Representative ultrathin
sections of femoral quadriceps nerves from 6-month-old IgG reconstituted P0wt JHD−/−, P0het JHD+/+ controls, and IgG reconstituted P0het
JHD−/− mice. Asterisks indicate abnormally myelinated fibers. Scale bar, 5 μm. (B, C) Quantification of abnormally myelinated fibers (B) and signs
of demyelination (onion bulbs) (C) in control and reconstituted mice reveal a significantly aggravated myelin degeneration in IgG reconstituted
P0het JHD−/− mutants. Note also a non-significant trend of increased pathological alterations in control-reconstituted animals (+KLH, +IgG Fc).
(n = 3 to 5). Kruskal-Wallis test with Bonferroni-Holm correction. *P < 0.05; **P < 0.01.
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the antibodies binding to the endoneurial tubes of our
CMT1B model share the same specificities. It is, how-
ever, presently not known why preexisting antibodies do
not accumulate to unlesioned wt nerves. It is likely that
the intact blood-nerve barrier is one explanation [16].
Additionally, it is plausible to assume that epitopes ‘hid-
den’ in normal myelin are only accessible under patho-
logical conditions. An argument in favor of the latter
hypothesis is that we failed to demonstrate an interrupted
blood-nerve barrier in our young CMT1B models
(Martini, unpublished).
In an approach using JHD−/− mice, lack of antibodies
led to lower macrophage numbers and mildly delayed
myelin removal by the phagocytes in the lesion model.
Additionally, likely as a consequence of prolonged persist-
ence of myelin debris [25], axonal regeneration was de-
layed in the absence of antibodies in the injured nerves
[16]. Thus, antibodies have a beneficial function under le-
sion conditions, whereas in the CMT model, antibodies
foster demyelination of initially almost normal nerve fibers
which are typical for young CMT1B mutants. This sup-
ports our view that in inherited demyelination, similar
mechanisms are working as in Wallerian degeneration
but lead to neural dysfunction when activated under
nonlesion conditions [5].
How might antibody deposition and macrophage-related
demyelination be interconnected?Phagocytotic performance of macrophages involves a
broad range of receptors for recognition, binding, and
incorporation, such as receptors for immunoglobulins and
complement or certain selectins [26]. The best known re-
ceptors for macrophages are complement receptor 3 (CR3;
also known as αMβ2, Mac-1 or CD11b) and the Fcγ recep-
tor [26-28]. Since the complement component C3 could
not be found associated to mutant nerve fibers or their
subcellular domains, we consider CR3 as being involved in
antibody-driven pathogenesis as unlikely. By contrast, the
macrophage-related Fcγ receptor, amply expressed on
nerve macrophages (unpublished observation), might be
an important mediator in functionally linking the innate
with the adaptive immune system in our models.
Interestingly, CSF-1, a nerve fibroblast-derived cyto-
kine that has pivotal activating impact on phagocytosing
macrophages in our models [8,11,29] has been reported
to be involved in Fcγ-receptor upregulation in macro-
phages under various pathological conditions [30]. Thus,
it is plausible to assume that CSF-1 not only leads to
intrinsic macrophage proliferation and activation [29]
but additionally ‘prepares’ macrophages for recognition
of antibody depositions.
Reconstitution experiments in P0het JHD−/− mice
using murine IgG antibodies reverted the beneficial ef-
fect of antibody deficiency. Interestingly, reconstitution
with antibodies specific to a non-mammalian antigen,
KLH, or with Fc fragments from murine IgG generated
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axons and onion bulbs were elevated in individual ani-
mals in comparison to non-reconstituted P0het JHD−/−
mice. Although the corresponding values in the recon-
stituted vs. non-reconstituted double mutants were not
statistically significantly different from each other, these
data may suggest that both antibodies bound to endoneur-
ial tubes and antibodies not target bound might have the
capacity to contribute to macrophage activation.
We have shown that, in an early stage of genetically-
induced demyelination, systemic, preexisting antibodies link
the adaptive and innate immune system during the
macrophage-mediated demyelinating process. Of particular
note is the preferential deposition of antibodies in the fem-
oral quadriceps as opposed to the saphenous nerve, as the
latter nerve is preserved from myelin degeneration and in-
flammation [31,32]. It is possible that binding of antibodies
might contribute to MCP-1 and - indirectly - CSF-1 expres-
sion in quadriceps nerves which are important activators of
macrophages in our models [5]. However, in the absence of
antibodies, myelin destruction is not as prominently
blocked as with MCP-1 reduction [9] or CSF-1 deficiency
[8]. This might imply that antibodies at early stages of dis-
ease might have an amplifying rather than causative role of
myelin degeneration in quadriceps nerves of P0het mice.
Surprisingly, at older ages, JHD deficiency has obviously
a diametrically opposite effect in P0het mice as they reveal
increased macrophage activation and subsequent aggra-
vated demyelination. Likely, based on our unpublished
observations, this effect is maybe due to altered cytokine
profiles caused by B-lymphocyte deprivation. Indeed, B-
lymphocyte deficiency triggers an alternative macrophage
response in 12-month-old P0het mice as measured by
qRT-PCR (Klein, Martini unpublished), similar to observa-
tions after acute nerve injury [33]. Taken together, it is
presently difficult to decide whether the absence of anti-
bodies or the altered cytokine profile due to B-lymphocyte
deficiency aggravates the phenotype at older ages.
In the present study, we provide evidence for a patho-
genic role of antibodies in a model for a distinct inherited
demyelinating neuropathy. Interestingly, in some vigorous
forms of CMT, IVIG treatment was helpful [34]. However,
it is presently difficult to estimate whether the observations
in these case reports can be taken as a hint of a role of
endogenous antibodies in the patients, since IVIGs fulfill
multiple functions at various levels of the innate and
adaptive immune system [35,36]. In summary, our study
extends our understanding of pathomechanisms pos-
sibly involved in inherited demyelinating neuropathies
in humans. Moreover, the present passive transfer approach
of specific antibodies into P0het JHD−/− mice may provide
an experimental setup to test identified human pathogenic
antibodies in detail with regard to their preferential subcel-
lular target site in diseased peripheral nerves [37,38].Competing interests
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